CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) Ticagrelor With or Without Aspirin After Complex PCI The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) Stress Echocardiography and PH: What Do the Findings Mean? Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

Review Article2018 Dec;7(2):127-149.

JOURNAL:Cardiol Ther. Article Link

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review

Mohiaddin H, Wong TDFK, Burke-Gaffney A et al. Keywords: coronary artery disease; de novo; drug-coated balloon; drug-eluting balloon; percutaneous coronary intervention

FULL TEXT PDF